Aladdin Scientific
Alobresib (C007B-021185)
InformationAlobresib (GS-5829) Alobresib (GS-5829) is a novel BET inhibitor that represents a highly effective therapeutics agent against recurrent/chemotherapy-resistant USC-overexpressing c-Myc. Alobresib (GS-5829) inhibits CLL cell proliferation
InformationAlobresib (GS-5829) Alobresib (GS-5829) is a novel BET inhibitor that represents a highly effective therapeutics agent against recurrent/chemotherapy-resistant USC-overexpressing c-Myc. Alobresib (GS-5829) inhibits CLL cell proliferation and induces leukemia cell apoptosis through deregulation of key signaling pathways, such as BLK , AKT , ERK1/2 , and MYC . Alobresib (GS-5829) also inhibits NF-κB signaling.TargetsBET ; BLK ; Akt ; ERK1/2 ; MYC 33297,In vitroIn-vitro experiments demonstrates high sensitivity of USC cell-lines to the exposure to GS-5829 causing a dose-dependent decrease in the phosphorylated levels of c-Myc and a dose-dependent increase in caspase activation (apoptosis). GS-5829 inhibits CLL cell proliferation and induces leukemia cell apoptosis through deregulation of key signaling pathways, such as BLK, AKT, ERK1/2, and MYC. IκBα modulation indicates that GS-5829 also inhibits NF-κB signaling. GS-5829-induced apoptosis results from an imbalance between positive (BIM) and negative regulators (BCL-XL) of the intrinsic apoptosis pathway.In vivoGS-5829 has impressive activity against USC primary tumors as well as USC xenografts. Assessment of c-Myc expression in tumors exposed to the GS-5829 demonstrates down-regulation of both total and phospho c-Myc proteins. GS-5829 demonstrates excellent bioavailability after oral administration and is significantly more effective than JQ1 at the doses used in comparative experiments in vivo against USC xenografts. Clinical studies with GS-5829 in USC patients harboring disease resistant to standard salvage chemotherapy are warranted.Cell Research(from reference)Cell lines:PBMC, MEC-1 Concentrations:100 nM, 200 nM, 400 nM, 800 nM Incubation Time:72 h, 24 h. Specification: 0.98 Molecular Formula: C26H23N5O2 Molecular Weight: 437.49 PubChem CID: 86281210 Isomeric SMILES: CC1=C(C(=NO1)C)C2=CC(=C3C(=C2)NC(=N3)C4CC4)C(C5=CC=CC=N5)(C6=CC=CC=N6)O Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/A414297-SCI_a01085b2d336db5af54eb0d21c830722.pdf
Specifications
- UPC:
- 51202411
- Condition:
- New
- Weight:
- 0.96 Ounces
- HazmatClass:
- No
- Quantity:
- 1
- Unit of Measurement:
- EA
- WeightUOM:
- LB
- MPN:
- A414297-10mg
- CAS:
- 1637771-14-2
- Product Size:
- 10mg
- Hazard Statement Codes:
- H302:H315:H319:H335
- Precautionary Statement Codes:
- P261:P264:P271:P280:P302+P352:P305+P351+P338:P332+P313:P337+P313:P405:P403+P233:P501:P304+P340+P312



